Rally (Ruby Reef)

Rally is a commercial aquarium medication produced by Ruby Reef, formulated with acriflavine as its primary active ingredient for treating external parasitic infections in marine and freshwater fish. The product has gained significant popularity in the marine aquarium hobby due to its manufacturer claims of reef compatibility, positioning it as an alternative to copper-based treatments that cannot be used in systems containing invertebrates. Rally represents one of several attempts by the aquarium industry to provide effective parasite treatment without the limitations imposed by traditional medications.

The mechanism of action relies on acriflavine's properties as an antiseptic dye compound that interferes with parasitic reproduction and damages parasitic organisms through disruption of nucleic acid function. Acriflavine has historical use dating back over a century as an antiseptic and has been employed in aquaculture for treating various external conditions. The compound's broad antimicrobial properties provide some activity against bacteria as well as parasites, though its primary marketing focuses on antiparasitic applications. The exact formulation of Rally includes additional proprietary ingredients that Ruby Reef states enhance effectiveness and safety.

Rally is available as a liquid concentrate designed for direct addition to aquarium water, with dosing based on tank volume. The product produces a characteristic yellow-green coloration in treated water from the acriflavine dye. Ruby Reef markets Rally as safe for use in reef aquariums with corals and invertebrates, distinguishing it from copper and formalin treatments that kill invertebrates. This claimed reef compatibility represents the product's primary selling point and drives most purchase decisions among marine aquarists seeking parasite treatment options for mixed reef systems.

The effectiveness of Rally remains a subject of considerable debate within the marine aquarium community. While the manufacturer claims efficacy against marine ich (Cryptocaryon irritans), velvet (Amyloodinium ocellatum), and other external parasites, many experienced aquarists report inconsistent results, particularly for established infections. Scientific validation of acriflavine's effectiveness against Cryptocaryon at aquarium-safe concentrations is limited. Aquarists considering Rally should understand these controversies and set appropriate expectations, viewing the product as a potential prophylactic or mild treatment rather than a proven cure for advanced parasitic infections.

The primary marketed indication for Rally is treatment of marine ich (Cryptocaryon irritans) in situations where copper-based treatments cannot be used due to invertebrate presence. Aquarists with reef tanks experiencing ich outbreaks face limited options; copper and hyposalinity kill invertebrates, while removing fish for treatment in a hospital tank may be impractical. Rally offers a potential treatment that can theoretically be applied directly to reef systems without harming corals and invertebrates, though the efficacy of this approach remains controversial among experienced marine aquarists.

Velvet disease (Amyloodinium ocellatum) is listed among Rally's target conditions, offering hope for treating this deadly parasite in reef environments. Velvet progresses rapidly and often kills fish before they can be removed for hospital tank treatment. Having an in-tank treatment option could theoretically save fish that would otherwise be lost. However, the aggressive nature of velvet demands highly effective treatment, and aquarists with confirmed velvet infections should carefully consider whether Rally's uncertain efficacy justifies delaying proven treatments that require fish removal.

Brooklynella hostilis and other external protozoan parasites represent additional labeled indications for Rally treatment. The broad-spectrum antimicrobial properties of acriflavine provide some activity against various external pathogens. Rally's manufacturer suggests effectiveness against a range of parasitic conditions affecting marine fish. Prophylactic use during quarantine is sometimes recommended to reduce parasite introduction risk without the more involved protocols of copper treatment or hyposalinity.

Freshwater applications of Rally include treatment of ich (Ichthyophthirius multifiliis), velvet (Oodinium), and other external parasites affecting freshwater fish. The product's mild formulation may be particularly suited to freshwater species with medication sensitivities. However, established freshwater treatments including malachite green, formalin combinations, and temperature manipulation provide well-validated alternatives with decades of proven use.

The decision to use Rally should consider the specific circumstances, available alternatives, and realistic assessment of likely outcomes. Rally may be most appropriate for prophylactic use during quarantine, mild or early-stage infections, situations where fish removal is impractical, or as part of combination approaches. For established infections requiring rapid parasite elimination, proven treatments like copper (in fish-only systems), hyposalinity, or formalin baths generally offer more reliable outcomes despite their greater inconvenience or system limitations.

Standard dosing for Rally follows manufacturer recommendations of one ounce (approximately 30 mL) per 50 gallons of actual water volume. This dosing applies to both marine and freshwater applications. Accurate measurement of tank volume, accounting for displacement from rocks, substrate, and equipment, ensures proper concentration. The product should be added to a high-flow area of the tank for rapid distribution throughout the system, such as near a powerhead outlet or return pump discharge.

Initial treatment protocol typically involves dosing on day one, then repeating the dose on days three and five for a total of three treatments over five days. This repeated dosing addresses parasite life cycle stages as they progress through phases vulnerable to treatment. Some protocols extend treatment to seven days with additional doses, particularly for established infections or prophylactic quarantine treatment. Following the manufacturer's specific protocol for the condition being treated maximizes potential effectiveness.

Maintenance dosing may be employed in reef systems where ongoing low-level parasite pressure exists but removing fish for treatment is impractical. Some aquarists add Rally at reduced frequency, such as weekly, as a suppressive measure rather than curative treatment. This approach attempts to reduce parasite reproduction and transmission while accepting that complete elimination in a reef system may not be achievable without removing fish for proper treatment.

Combination protocols using Rally with the companion product Kick-Ich are recommended by Ruby Reef for enhanced effectiveness. The company suggests alternating or combining these products attacks parasites through complementary mechanisms. Following manufacturer combination protocols rather than improvising independent approaches ensures the intended interaction between products. Some aquarists report better results with combination treatment than with either product alone.

Water changes during Rally treatment should be minimized to maintain therapeutic concentrations. If water changes become necessary for quality reasons, replacement water should be dosed with Rally to maintain consistent medication levels. Following treatment completion, activated carbon can be used to remove residual medication, though Rally naturally degrades in aquarium water over time. The yellow-green water coloration fades as acriflavine breaks down, providing visual indication of declining medication levels.

Treatment in hospital tanks follows the same dosing protocol but offers advantages of controlled environment, easier observation, and the option to increase dosing or switch treatments if Rally proves ineffective. Using Rally in a hospital tank first allows assessment of effectiveness before committing to reef-tank treatment. This staged approach provides information while preserving the option of proven treatments if Rally fails to control the infection.

Fish generally tolerate Rally treatment without significant adverse effects when dosed according to manufacturer recommendations. Some fish may show temporary behavioral changes including reduced activity or altered feeding during initial treatment, though these effects are typically mild compared to copper or formalin exposure. Most fish continue normal behavior throughout Rally treatment, representing one advantage of this milder formulation. Individual sensitivity varies, and any fish showing signs of unusual distress should prompt treatment evaluation.

Biological filtration typically remains functional during Rally treatment, with nitrifying bacteria tolerating acriflavine concentrations used for parasite treatment. This preservation of the nitrogen cycle represents a significant advantage over many alternative treatments that crash biological filtration. However, aquarists should still monitor ammonia and nitrite levels during treatment, as any medication introduction carries some risk of affecting bacterial populations. Maintaining normal feeding schedules is generally possible since biological filtration continues operating.

Live aquarium plants may experience some stress from acriflavine exposure, as the compound can affect plant cellular processes. Reports vary regarding plant tolerance, with some aquarists noting no effect and others observing minor leaf damage or growth slowdown. Sensitive plant species or heavily planted tanks may warrant caution with Rally use. Removing particularly valuable or sensitive plants during treatment provides protection if desired.

Invertebrate effects represent the critical consideration for Rally's target market of reef aquarists. Ruby Reef claims invertebrate safety at recommended doses, and many aquarists report using Rally in reef systems without obvious harm to corals or invertebrates. However, some sensitive invertebrates, particularly certain soft corals, anemones, and clams, may show stress responses during treatment. Long-term or repeated Rally exposure effects on invertebrates are not well documented. Aquarists should observe invertebrates closely during treatment and be prepared to perform water changes and carbon filtration if adverse effects appear.

Water coloration from Rally's acriflavine content produces a noticeable yellow-green tint that some aquarists find objectionable for aesthetic reasons. This coloration is temporary and fades as the medication degrades or is removed by carbon filtration. The intensity of coloration provides a rough visual indicator of medication concentration, though this should not replace proper dosing calculations. Some aquarists treat during lights-off periods when the coloration is less visible.

Severely infected fish with advanced parasitic disease may not be appropriate candidates for Rally treatment given the medication's uncertain efficacy against established infections. Fish showing heavy parasite loads, severe tissue damage, or systemic illness require more aggressive treatment approaches with proven effectiveness. Delaying effective treatment while attempting Rally risks fish loss when faster-acting medications might have succeeded. Rally is better suited to mild infections, early intervention, or prophylactic use than to treating fish in crisis.

Tank conditions with poor water quality compound treatment challenges regardless of medication choice, and Rally is no exception. Systems with elevated ammonia, nitrite, or accumulated organic matter place additional stress on fish that reduces their ability to fight infection and tolerate treatment. Addressing water quality issues before or concurrent with medication improves outcomes. Rally will not overcome fundamentally unhealthy tank conditions.

Specific invertebrate sensitivities, while not thoroughly documented, may contraindicate Rally use in tanks containing highly sensitive species. Tridacnid clams, some anemone species, and certain soft corals have shown stress responses to Rally in some reports, though other aquarists report no problems with the same species. When keeping particularly valuable or sensitive invertebrates, testing Rally effects in a separate system first or proceeding with extreme caution may be warranted. The claimed reef safety is not universal for all invertebrate species at all concentrations.

Situations requiring guaranteed parasite elimination contraindicate relying solely on Rally given the uncertainty surrounding its effectiveness. Quarantine protocols for high-value fish, elimination of parasites before introducing fish to established reef systems, or treatment of aggressive infections like velvet demand proven effective treatments. Rally may serve as an adjunct or mild-case treatment but should not be the sole intervention when treatment failure carries significant consequences.

Combining Rally with copper-based medications is unnecessary and not recommended, as copper provides superior antiparasitic activity that makes Rally's contribution marginal while adding complexity and potential interaction risks. If copper treatment is possible and appropriate, it should be used alone according to established protocols. The only scenario for considering both involves a staged transition where Rally is used in a reef display while fish are moved to a separate copper treatment system.

Kick-Ich, Ruby Reef's companion product, is specifically designed for combination use with Rally according to manufacturer protocols. The two products contain different active ingredients and are marketed as providing complementary antiparasitic mechanisms. Following manufacturer guidance for combination treatment ensures the intended interaction. Using these products together appears to be safe and may improve effectiveness compared to either product alone based on anecdotal reports.

Sequential treatment with other medications following Rally should allow adequate time between treatments to assess results and allow fish recovery. If Rally treatment fails to control infection, transitioning to more aggressive treatments may be necessary. Water changes and carbon filtration can remove Rally before introducing different medications. Waiting 24 to 48 hours after Rally removal before beginning alternative treatments provides a reasonable buffer.

Water conditioners and standard aquarium additives generally do not interact significantly with Rally. Dechlorinators, pH buffers, calcium supplements, and other routine reef aquarium additives can be used normally during Rally treatment. However, some water conditioners contain compounds that may bind to or reduce acriflavine activity; using simple dechlorinators without additional additives during treatment provides the most predictable results.

Activated carbon removal before Rally treatment is recommended by the manufacturer, as carbon absorbs acriflavine and reduces treatment effectiveness. All carbon filtration media, including filter cartridges, reactor media, and carbon bags, should be removed before dosing. Other chemical filtration media such as Purigen or phosphate removers may also absorb acriflavine to varying degrees and should be removed as a precaution. Carbon can be returned to filtration after treatment completion to help remove residual medication.

Protein skimmer adjustment may be necessary during Rally treatment, as acriflavine can cause excessive foaming in some skimmers. Over-skimming removes medication from the water and reduces treatment effectiveness while creating potential overflow issues. Reducing skimmer output, raising the collection cup, or temporarily disabling the skimmer during treatment maintains medication levels. Monitor skimmer behavior closely after Rally addition and adjust as needed.

UV sterilizers should be turned off during Rally treatment, as UV light degrades acriflavine and reduces medication concentration. The sterilizer pump can continue running for water circulation if the UV bulb is switched off, or the unit can be bypassed entirely. UV sterilization can resume after treatment completion and medication removal. Ozone systems should similarly be disabled during treatment.

Realistic expectations regarding effectiveness are essential when using Rally, as many experienced aquarists report inconsistent or disappointing results. Understanding that Rally may not eliminate established infections allows appropriate treatment planning, including backup options if Rally fails. Using Rally as one tool among several rather than a guaranteed cure prevents extended delays in seeking effective treatment. Fish health deteriorates during unsuccessful treatment attempts, reducing chances of eventual recovery.

Human safety during Rally handling involves standard precautions for any aquarium chemical. While acriflavine is generally considered to have low toxicity, avoiding skin and eye contact, keeping the product away from children, and washing hands after handling are prudent practices. The product should be stored as directed and kept in its original container with clear labeling.

Rally should be stored in its original container at room temperature, protected from direct sunlight and temperature extremes. The product contains acriflavine in aqueous solution that remains stable under normal storage conditions for extended periods. Keeping the container tightly sealed between uses prevents evaporation and concentration changes. Storage alongside other aquarium products poses no particular compatibility concerns.

Shelf life for Rally, while not typically printed on packaging with a specific expiration date, extends several years under proper storage conditions. Acriflavine solutions remain stable when protected from light and temperature extremes. Product that has developed unusual color, precipitation, or unusual odor should be replaced. When in doubt about product age or storage history, replacing with fresh product ensures reliable concentration and effectiveness.

Disposal of Rally follows standard practices for aquarium chemicals with low toxicity profiles. Small quantities in treated water can be disposed of through normal water changes and municipal sewer systems. Unused product should be disposed of according to local regulations for household chemicals. The acriflavine dye component may stain surfaces and should be handled carefully to avoid spills. The relatively benign nature of Rally compared to more toxic medications like copper or formalin simplifies disposal concerns.

Marine fish species generally tolerate Rally treatment without species-specific concerns, as the mild formulation produces minimal stress compared to more aggressive medications. Hardy species including clownfish, damselfish, tangs, and wrasses typically show no adverse effects at recommended doses. More sensitive species including seahorses, pipefish, and dragonets, which often cannot tolerate copper treatment, may find Rally a useful alternative, though effectiveness against their parasites must still be considered.

Sensitive marine species that react poorly to other medications may tolerate Rally's gentler formulation. Scaleless fish and those with delicate gill tissue that suffer from formalin or copper exposure may handle Rally without distress. However, the trade-off involves potentially reduced effectiveness against the parasites being treated. Aquarists must weigh the benefits of a tolerable medication against the risks of treatment failure.

Invertebrate species vary in their Rally tolerance despite general claims of reef safety. Most stony corals appear to tolerate Rally well at recommended doses based on widespread use reports. Soft corals show more variable responses, with some sensitive species displaying polyp retraction or tissue irritation. Clams, particularly Tridacna species, warrant careful observation during treatment. Shrimp and crabs generally tolerate Rally, though individual reports of sensitivity exist. Testing Rally's effects on a system before committing to treatment, or close observation with readiness to perform water changes, protects valuable invertebrates.

Species-specific dosing adjustments are generally not necessary for Rally given its mild formulation and wide safety margin. Unlike copper, where sensitive species require reduced concentrations, Rally's gentle action allows standard dosing across species. The primary variable in treatment decisions involves not fish tolerance but assessment of whether Rally will prove effective against the specific infection and parasite load present. This effectiveness question, rather than fish sensitivity, typically determines Rally's appropriateness for a given treatment situation.

Kick-Ich, another Ruby Reef product, serves as Rally's companion medication designed for combination use against parasitic infections. Kick-Ich contains different active ingredients than Rally and is marketed as providing complementary antiparasitic mechanisms. Many aquarists use both products together following manufacturer protocols. Kick-Ich faces similar effectiveness debates as Rally within the aquarium community, with reports ranging from strong success to complete ineffectiveness.

Copper-based medications including Cupramine, Copper Power, and copper sulfate provide proven antiparasitic activity that represents the gold standard for marine ich and velvet treatment in fish-only systems. Copper's effectiveness is well-established through decades of professional and hobbyist use. The trade-off involves absolute invertebrate incompatibility and potential copper sensitivity in certain fish species. When copper treatment is possible, it generally provides more reliable outcomes than Rally for established infections.

Chloroquine phosphate offers another alternative for marine parasite treatment with different characteristics than either Rally or copper. Chloroquine works through different mechanisms and may succeed where other treatments fail. Availability and dosing complexity present challenges, but chloroquine provides a valuable option for resistant infections or situations requiring alternatives to standard medications. Some aquarists report invertebrate tolerance at certain chloroquine concentrations, though this requires careful attention.